← Back
Data updated: Jun 28, 2026
GENERAL SERVICES & SUPPLY CO
Pharma Pharmaceuticals
GENERAL SERVICES & SUPPLY CO is a pharmaceutical company with 1 FDA-approved products.
2016
Since
1
Drugs
-
Trials
2
New Drugs (2yr)
Modality:
1 Small Molecules
GENERAL SERVICES & SUPPLY CO's Key Drugs
GENERAL SERVICES & SUPPLY CO's core commercial portfolio centers on MEDICAL AIR, USP — its most strategically important drugs approved in the last 15 years.
GENERAL SERVICES & SUPPLY CO's Recent FDA Approvals
GENERAL SERVICES & SUPPLY CO secured 2 new FDA approvals for novel drugs (NDA/BLA) in the last two years.
GENERAL SERVICES & SUPPLY CO's Therapeutic Areas
Disease areas where GENERAL SERVICES & SUPPLY CO has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
GENERAL SERVICES & SUPPLY CO Pipeline Snapshot
Active clinical trials for GENERAL SERVICES & SUPPLY CO across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • MEDICAL AIR, USP leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2016-12-25
- Latest
- 2016-12-25
- Applications
- 1